Australia | Apr 19 2006
With Austal Limited (ASB) set to expand its operations in the US market UBS has reviewed its model on the company, the result being an upgrade in its rating to Buy 2 from Neutral 2.
The upgrade also sees an increase in the broker’s target price to $3.10 from $1.93, the new target reflecting its view the company’s share price is not a full reflection of its growth prospects in the US.
The company has indicated its forward order book for the next two years stands at about $650m, with the broker factoring in this and the commencement of work on two US contracts when lifting its earnings forecast for FY08 by more than 20%.
While this earnings boost is a longer-term benefit, the broker also sees some shorter-term positives given there remains potential for new contracts and contract extensions, while the outcome of the ASC scoping study is also a potential positive.
Putting all this together leads the broker to suggest the stock may begin to receive more recognition from the market in the medium-term, especially if it can continue to move from contract-based earnings, which by nature are irregular, to annuity style earnings as are being generated from its US military contracts.
Assuming the stock reached its $3.10 target price, the broker calculates it would be trading at around 13x FY08 earnings while offering a dividend yield of more than 5%. The combined returned return on the stock for the next 12 months is estimated by the broker at more than 22%, which equates to an excess return of 11.6%.
Austal is not widely covered in the Australian market, the FN Arena database showing among the leading stockbrokers and equity researchers the stock is rated as Buy three times and Accumulate once.
The last sale price for ASB was $2.70.

